Soviero Asset Management’s Altimmune ALT Stock Holding History

Soviero Asset Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-400,000	Closed	-$1.44M	–	61
2025 Q4	$1.44M	Buy	+400,000	New	+$1.74M	0.69%	56

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Soviero Asset Management's ALT Position: Q1 2026 in Review

Soviero Asset Management sold out of Altimmune (ALT) in Q1 2026, closing a stake of 400,000 shares — an estimated $1.44M sold.

Soviero Asset Management first reported a position in ALT in Q4 2025 and held it in 1 quarter. The position peaked at $1.44M in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

Soviero Asset Management reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
Soviero Asset Management sold 400,000 Altimmune shares in Q1 2026, an estimated $1.44M.
Soviero Asset Management first reported a position in Altimmune in Q4 2025 and held it in 1 quarter.
Soviero Asset Management's Altimmune position peaked at $1.44M in Q4 2025.
173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Soviero Asset Management's 13F filing for Q1 2026, filed 15 May 2026.